Pluri Inc.
Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
Description
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-22 01:30 |
FORM 10-K-For the fiscal year ended June 30, 2022
|
English | 671.7 KB | ||
| 2022-09-22 01:30 |
FORM 10-K-For the fiscal year ended June 30, 2022
|
English | 36.2 KB | ||
| 2022-09-06 16:01 |
€7.5 Million Granted to Collaborative PROTO Project led by Charit? to
Study Plu…
|
English | 82.6 KB | ||
| 2022-09-06 16:01 |
€7.5 Million Granted to Collaborative PROTO Project led by Charit? to
Study Plu…
|
English | 35.9 KB | ||
| 2022-07-28 14:15 |
Following our circular regarding the company's name change, the ISIN was change…
|
Hebrew (modern) | 146.5 KB | ||
| 2022-07-26 13:39 |
Immediate Report about Change of Name -PLURI INC
|
English | 36.5 KB | ||
| 2022-07-25 19:17 |
Changes in company's name: PLURI INC
|
Hebrew (modern) | 150.6 KB | ||
| 2022-07-25 18:48 |
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.”
|
English | 2.0 MB | ||
| 2022-07-25 18:48 |
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.”
|
English | 36.0 KB | ||
| 2022-07-25 16:00 |
Pluri CEO Issues Shareholder Update
|
English | 93.9 KB | ||
| 2022-07-25 16:00 |
Pluri CEO Issues Shareholder Update
|
English | 35.9 KB | ||
| 2022-07-25 10:00 |
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.”
|
English | 125.8 KB | ||
| 2022-07-25 10:00 |
Pluristem Therapeutics Inc. Changes its Name to “Pluri Inc.”
|
English | 36.0 KB | ||
| 2022-07-13 18:43 |
FORM 8-K-e results from its Phase III Study of muscle regeneration following hi…
|
English | 101.4 KB | ||
| 2022-07-13 18:43 |
FORM 8-K-e results from its Phase III Study of muscle regeneration following hi…
|
English | 36.0 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
